|
|
Volumn 44, Issue 1, 2007, Pages 18-19
|
|
Autoimmune hepatitis: Are we using the right therapy?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
TACROLIMUS;
AUTOIMMUNE HEPATITIS;
AUTOIMMUNITY;
CELLULAR IMMUNITY;
CLINICAL EXAMINATION;
CYTOSOL;
EDITORIAL;
EVALUATION;
GENETIC SUSCEPTIBILITY;
GINGIVA HYPERPLASIA;
HUMAN;
HYPERTENSION;
HYPERTRICHOSIS;
NONHUMAN;
PRIORITY JOURNAL;
SIDE EFFECT;
UNSPECIFIED SIDE EFFECT;
ADOLESCENT;
ANIMALS;
AZATHIOPRINE;
CHILD;
CYCLOSPORINE;
DISEASE MODELS, ANIMAL;
GENETIC PREDISPOSITION TO DISEASE;
GLUCOCORTICOIDS;
HEPATITIS, AUTOIMMUNE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MICE;
TACROLIMUS;
|
|
EID: 33846094517
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/MPG.0b013e31802c8aa3 Document Type: Editorial |
|
Times cited : (2)
|
|
References (4)
|
